Max Robotics — Global Service Robot Directory + US Certification

About

Dianrong Xiu is a leading figure in the surgical management of pancreatic disease, with a focused expertise in minimally invasive techniques for obese patients. His research critically evaluates the comparative effectiveness of robotic versus laparoscopic distal pancreatectomy, demonstrating that the robotic approach significantly reduces conversion rates to open surgery and minimizes intraoperative blood loss. Xiu’s work has been instrumental in identifying the specific challenges and outcomes for high-BMI populations, a group historically at greater risk for complications. His multicenter analyses, including a 2024 study on conversion factors, have provided actionable insights for surgical decision-making. With a growing body of highly cited work—including studies on pancreatic adenocarcinoma and spleen-preserving techniques—Xiu has advanced the understanding of how to reduce clinically relevant pancreatic fistulas in obese patients. His contributions are shaping modern pancreatic surgery protocols, offering evidence that robotic platforms can improve both perioperative safety and oncological outcomes. Xiu’s research is essential reading for surgeons and trainees seeking to optimize care for this challenging patient demographic.